rxstat › Shortages › Escitalopram

Escitalopram (Cipralex Meltz, Cipralex -20mg) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Nov 6, 2026

Some Escitalopram products are in shortage in Canada (2 of 41 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 8, 2027.

An antidepressant (SSRI) used to treat depression and anxiety disorders.

Products affected
2 / 41
In shortage since
Jun 17, 2026
Est. full return
Jan 8, 2027
Reports on file
170
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TEVA-ESCITALOPRAM
10MG · TABLET · TEVA CANADA LIMITED
DIN 02318180 · since Jun 17, 2026, est. end Dec 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
ESCITALOPRAM
10MG · TABLET · SANIS HEALTH INC
DIN 02430118 · since Aug 5, 2026, est. end Jan 8, 2027 · Disruption of the manufacture of the drug.
Anticipated
ESCITALOPRAM
20MG · TABLET · SANIS HEALTH INC
DIN 02430126 · Disruption of the manufacture of the drug.
Resolved
ACH-ESCITALOPRAM
20MG · TABLET · ACCORD HEALTHCARE INC
DIN 02434660 · ended Oct 30, 2026 · Delay in shipping of the drug.
Resolved
ACH-ESCITALOPRAM
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02434652 · ended Oct 13, 2026 · Demand increase for the drug.
Resolved
TEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · ended Jul 31, 2026 · Disruption of the manufacture of the drug.
Resolved
ACH-ESCITALOPRAM
20MG · TABLET · ACCORD HEALTHCARE INC
DIN 02434660 · ended Jul 9, 2026 · Demand increase for the drug.
Resolved
TEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · ended Jun 9, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · ended Jun 10, 2026 · Disruption of the manufacture of the drug.
Discontinued
PMS-ESCITALOPRAM
20MG · TABLET · PHARMASCIENCE INC
DIN 02469251
Resolved
PMS-ESCITALOPRAM
20MG · TABLET · PHARMASCIENCE INC
DIN 02469251 · ended May 4, 2026 · Disruption of the manufacture of the drug.
Resolved
PMS-ESCITALOPRAM
20MG · TABLET · PHARMASCIENCE INC
DIN 02469251 · ended May 4, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Escitalopram is currently affected by 2 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, SANIS HEALTH INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Escitalopram is classified under “ANTIDEPRESSANTS” (ATC N06AB).

Recent changes

Common questions

What is Escitalopram used for?

An antidepressant (SSRI) used to treat depression and anxiety disorders.

When will Escitalopram be back in stock in Canada?

The latest manufacturer estimate is Jan 8, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Escitalopram in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antidepressants)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Clomipramine (Anafranil) No current shortage Fluvoxamine (Luvox) No current shortage Imipramine No current shortage Moclobemide (Manerix) No current shortage Nortriptyline (Aventyl) No current shortage Trimipramine No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.